by Kelley Tracy | Sep 3, 2014 | Uncategorized
The Fox Chase Chemical Diversity Center is Pleased to Announce That it Has Been Awarded a Phase I STTR Entitled “Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV/AIDS” Doylestown, PA. September 3, 2014- FCCDC is pleased to announce that it...
by Kelley Tracy | Jun 16, 2014 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase II SBIR Grant With the Title “A Novel Therapeutic for Invasive Candidiasis” Doylestown, PA. June 16, 2014- FCCDC is pleased to announce that it has been awarded a Phase II SBIR grant (R44...
by Kelley Tracy | May 17, 2014 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase I STTR Grant From the National Heart, Lung, and Blood Institute Entitled “Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT” Doylestown, PA. May 17, 2014- FCCDC is...
by Kelley Tracy | Dec 31, 2013 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it Has Submitted it’s 3,000th Small Molecule Test Compound Doylestown, PA. December 31, 2013- FCCDC is pleased to announce that as of today it has submitted it’s 3,000th small molecule test compound in support of...
by Kelley Tracy | Aug 23, 2013 | Uncategorized
The Fox Chase Chemical Diversity Center Announces that it Has Been Awarded a Phase I STTR Grant Together With Prof. Harvey Rubin of the University of Pennsylvania, “New Therapeutics for the Treatment of Acinetobactor baumannii Infections,” Totaling $300,000...
